THE ASSOCIATION BETWEEN EXPRESSION OF UCP2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA

被引：0
|
作者：
Kawanishi, M. [1 ]
Fukuda, T. [1 ]
Inoue, Y. [1 ]
Shimomura, M. [1 ]
Matsubara, H. [1 ]
Wada, T. [1 ]
Tasaka, R. [1 ]
Yasui, T. [1 ]
Sumi, T. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Obstet & Gynecol, Osaka, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0211
引用
收藏
页码：1495 / 1495
页数：1
相关论文
共 50 条
  • [21] Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study
    Valenza, Carmine
    Mongillo, Marta
    Boldrini, Laura
    Guidi, Lorenzo
    Farfalla, Alessia
    Malengo, Daniela
    Caruso, Giuseppe
    Lapresa, Mariateresa
    Parma, Gabriella
    Biagioli, Elena
    Curigliano, Giuseppe
    Colombo, Nicoletta
    Visconti, Maria Vittoria
    Katrini, Jalissa
    Trapani, Dario
    Derio, Silvia
    GYNECOLOGIC ONCOLOGY, 2025, 194 : 11 - 17
  • [22] Platinum-based chemotherapy inflames the ovarian carcinoma microenvironment through cellular senescence
    Alvarez-Abril, Beatriz
    Garcia-Martinez, Elena
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [23] PREDICTING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR TUBO-OVARIAN HIGHGRADE SEROUS CARCINOMA USING AN ARTIFICIAL INTELLIGENCE HISTOPATHOLOGY PLATFORM
    Tiu, Ekin
    Krishna, Vrishab
    Nimgaonkar, Vivek
    Krishnan, Rayan
    Bhambhvani, Hriday
    O'Donoghue, Odhran
    Vrabac, Damir
    Joshi, Anirudh
    Liang, Brooke
    Zhang, Xiaoming
    Han, Lucy
    Wang, Aihui
    Krishna, Viswesh
    Howitt, Brooke
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A46 - A47
  • [24] The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC)
    Dietrich, CS
    Modesitt, SC
    DePriest, PD
    Ueland, FR
    Wilder, J
    Reedy, MB
    Pavlik, EJ
    Kryscio, R
    Cibull, M
    Giesler, J
    Manahan, K
    Huh, W
    Cohn, D
    Powell, M
    Slomovitz, B
    Higgins, R
    Merritt, W
    Hunter, J
    Puls, L
    Gehrig, P
    van Nagell, JR
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 557 - 563
  • [25] High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma
    Kim, Chul Jung
    Lee, Jeong-Won
    Choi, Jung-Joo
    Choi, Hye Young
    Park, Young-Ae
    Jeon, Hye-Kyung
    Sung, Chang Ohk
    Song, Sang Yong
    Lee, Yoo-Young
    Choi, Chel Hun
    Kim, Tae-Joong
    Lee, Je-Ho
    Kim, Byoung-Gie
    Bae, Duk-Soo
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (06) : 918 - 925
  • [26] Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer
    Alkema, N. G.
    Tomar, T.
    van der Zee, A. G. J.
    Everts, M.
    Meersma, G. J.
    Hollema, H.
    de Jong, S.
    van Vugt, M. A. T. M.
    Wisman, G. B. A.
    GYNECOLOGIC ONCOLOGY, 2014, 133 (03) : 591 - 598
  • [27] Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
    Feng, Zheng
    Shao, Di
    Cai, Yuhang
    Bi, Rui
    Ju, Xingzhu
    Chen, Dongju
    Song, Chengcheng
    Chen, Xiaojun
    Li, Jin
    An, Na
    Li, Yunjin
    Zhou, Qing
    Xiu, Zhihui
    Zhu, Shida
    Wu, Xiaohua
    Wen, Hao
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [28] Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 273 - 274
  • [29] Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
    Zheng Feng
    Di Shao
    Yuhang Cai
    Rui Bi
    Xingzhu Ju
    Dongju Chen
    Chengcheng Song
    Xiaojun Chen
    Jin Li
    Na An
    Yunjin Li
    Qing Zhou
    Zhihui Xiu
    Shida Zhu
    Xiaohua Wu
    Hao Wen
    Journal of Ovarian Research, 16
  • [30] Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy
    Hans Bösmüller
    Sophie Haitchi-Petnehazy
    Gerald Webersinke
    Renate Marschon
    Franz Roithmeier
    Wolfgang Stummvoll
    Tanja Fehm
    Margit Klier-Richter
    Irina Bonzheim
    Annette Staebler
    Falko Fend
    Virchows Archiv, 2011, 459
12345